| 摘要 |
<p>The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, and L<SUB>2</SUB>, are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.</p> |
| 申请人 |
ABBOTT LABORATORIES;DART, MICHAEL J.;CARROLL, WILLIAM A.;FLORJANCIC, ALAN S.;FROST, JENNIFER M.;GALLAGHER, MEGAN E.;KOLASA, TEODOZYJ;LI, TONGMEI;NELSON, DEREK W.;PATEL, MEENA V.;PEDDI, SRIDHAR;PEREZ-MEDRANO, ARTURO;RYTHER, KEITH B.;TIETJE, KARIN ROSEMARIE |
发明人 |
DART, MICHAEL J.;CARROLL, WILLIAM A.;FLORJANCIC, ALAN S.;FROST, JENNIFER M.;GALLAGHER, MEGAN E.;KOLASA, TEODOZYJ;LI, TONGMEI;NELSON, DEREK W.;PATEL, MEENA V.;PEDDI, SRIDHAR;PEREZ-MEDRANO, ARTURO;RYTHER, KEITH B.;TIETJE, KARIN ROSEMARIE |
